Your session is about to expire
← Back to Search
Ruxolitinib Cream for Lichen Planus
Study Summary
This trial will study a cream to treat a skin condition called Lichen Planus, to see if it is effective and safe.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a condition that weakens my immune system.I have not taken antibiotics or antivirals for infections in the last 2 weeks.If you have an itch score of 4 or higher before starting the treatment.You have an itch score of 4 or higher before starting treatment.My condition mainly affects my skin.Your IGA score is 3 or 4 when checked before and at the start of the study.My condition mainly affects my skin.You agree not to get pregnant or make someone pregnant during the study.I haven't had skin infections like cold sores, shingles, or impetigo in the past week.My condition mainly affects my skin.Your lab test results don't meet the study's specific criteria.I do not have skin conditions that could affect the study of my LP lesions.You have another skin condition that could make it difficult to evaluate the study's target skin issues or might not be safe for you to participate.My condition affects areas like the mouth or genitals and is not suitable for creams or ointments.Your IGA score is 3 or 4 during the screening and at the start of the study.
- Group 1: Ruxolitinib cream
- Group 2: Vehicle Cream
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
When can patients expect Ruxolitinib cream to be available?
"Ruxolitinib cream is a medication that is currently being trialed in Phase 2 clinical trials. This suggests that while there is evidence of safety, there is no data yet to support its efficacy."
Are there several sites running this study in other developed countries?
"There are 6 available for this trial including Arlington Center For Dermatology in Arlington, Oregon Medical Research Center in Portland, and Clinohio Research Services in Columbus. The other locations where the study is being conducted have not been specified."
Are researchers currently looking for participants for this trial?
"Unfortunately, this particular trial is no longer enrolling patients. This is according to the clinicaltrials.gov website, which also reports that the last edit to this study was on 11/7/2022. Although this specific study has ended recruitment, there are 13 other trials that are still looking for candidates."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger